EarlyDiagnostics’ MethylScan Platform Shows Promise for Multi-Disease Detection in New PNAS Study

A new peer-reviewed study highlights a potential breakthrough in early disease detection, as California-based biotech firm EarlyDiagnostics reports strong validation results for its blood-based diagnostic platform. The findings, published in a leading U.S. scientific journal, suggest the technology could help…

Back to top